☰

Rachel M. Presti, Ph.D. - Publications

Affiliations: 
2001 Washington University, Saint Louis, St. Louis, MO 
Area:
Immunology, Microbiology Biology
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hevey MA, Presti RM, OʼHalloran JA, Larson L, Raval K, Powderly WG, Spec A. Mortality After Cryptococcal Infection in the Modern Antiretroviral Therapy Era. Journal of Acquired Immune Deficiency Syndromes (1999). 82: 81-87. PMID 31408451 DOI: 10.1097/Qai.0000000000002095  0.337
2019 Ma J, Non L, Amornsawadwattana S, Olsen MA, Garavaglia Wilson A, Presti RM. Hepatitis C care cascade in HIV patients at an urban clinic in the early direct-acting antiviral era. International Journal of Std & Aids. 956462419832750. PMID 31159714 DOI: 10.1177/0956462419832750  0.366
2019 Escota G, Baker J, Bush T, Conley L, Brooks JT, Patel P, Powderly W, Presti R, Overton ET. Aging attenuates the association between coronary artery calcification and bone loss among HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 31107297 DOI: 10.1097/Qai.0000000000002092  0.307
2018 Presti RM, Handley SA, Droit L, Ghannoum M, Jacobson M, Shiboski CH, Webster-Cyriaque J, Brown T, Yin MT, Overton ET. Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status. Aids (London, England). 32: 1279-1287. PMID 29851662 DOI: 10.1097/Qad.0000000000001811  0.394
2018 Hevey M, Raval K, Presti R, Powderly W, Spec A. 397. Long-Term Mortality of HIV Patients Following Cryptococcal Infection Open Forum Infectious Diseases. 5: S153-S153. DOI: 10.1093/Ofid/Ofy210.408  0.363
2018 Ma J, Salter A, Presti R, Korenblat K. 2253. Comparison of Cardiovascular Risk in Patients Infected With HIV and Hepatitis C Open Forum Infectious Diseases. 5: S666-S667. DOI: 10.1093/Ofid/Ofy210.1906  0.37
2017 Escota GV, O'Halloran JA, Powderly WG, Presti RM. Understanding mechanisms to promote successful aging in persons living with HIV. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 29154830 DOI: 10.1016/J.Ijid.2017.11.010  0.391
2017 Presti RM, Flores SC, Palmer BE, Atkinson JJ, Lesko CR, Lau B, Fontenot AP, Roman J, McDyer JF, Twigg HL. Mechanisms Underlying HIV Associated Non-infectious Lung Disease. Chest. PMID 28427967 DOI: 10.1016/J.Chest.2017.04.154  0.333
2017 Non L, Ali N, Presti R, Powderly W, Escota G. Statin Utilization Among Human-Immunodeficiency Virus (HIV)-Infected Individuals Based on the 2013 American College of Cardiology and American Heart Association (ACC/AHA) Blood Cholesterol Guideline Open Forum Infectious Diseases. 4: S214-S215. DOI: 10.1093/Ofid/Ofx163.430  0.37
2017 McBride D, Hu Q, Wong A, Baum C, Powderly W, Presti R, Clifford D, Ances B, Young A, Agbo O, Escota G. Stroke Outcomes Among HIV-infected Patients in a Large, Urban, Tertiary Hospital in the USA, 1999–2016 Open Forum Infectious Diseases. 4: S206-S207. DOI: 10.1093/Ofid/Ofx163.404  0.326
2017 Hlatshwayo M, Sahagun A, Atkinson J, Presti R. Smoking and Opportunistic Infections Contribute to High Rates of Respiratory Symptoms Among HIV-Infected Smokers Open Forum Infectious Diseases. 4: S587-S588. DOI: 10.1093/Ofid/Ofx163.1541  0.366
2016 Shacham E, Estlund AL, Tanner AE, Presti R. Challenges to HIV management among youth engaged in HIV care. Aids Care. 1-8. PMID 27397139 DOI: 10.1080/09540121.2016.1204422  0.372
2016 Williams B, Landay A, Presti RM. Microbiome alterations in HIV infection a review. Cellular Microbiology. 18: 645-51. PMID 26945815 DOI: 10.1111/Cmi.12588  0.42
2016 Non L, Ma J, Amornsawadwattana S, Garavaglia-Wilson A, Presti R. The Care Cascade of Hepatitis C Management With Direct-Acting Antivirals in HIV-Infected Individuals Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1693  0.371
2015 Escota G, Karpe V, Wu J, Tang M, Presti R, Powderly W. Lower CD4 Cell Count Is Independently Associated With Unsuccessful Physical Aging Among HIV-Infected Persons Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.1218  0.37
2014 Lennox JL, Landovitz RJ, Ribaudo HJ, Ofotokun I, Na LH, Godfrey C, Kuritzkes DR, Sagar M, Brown TT, Cohn SE, McComsey GA, Aweeka F, Fichtenbaum CJ, Presti RM, Koletar SL, et al. Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. Annals of Internal Medicine. 161: 461-71. PMID 25285539 DOI: 10.7326/M14-1084  0.373
2012 Handley SA, Thackray LB, Zhao G, Presti R, Miller AD, Droit L, Abbink P, Maxfield LF, Kambal A, Duan E, Stanley K, Kramer J, Macri SC, Permar SR, Schmitz JE, et al. Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome. Cell. 151: 253-66. PMID 23063120 DOI: 10.1016/J.Cell.2012.09.024  0.434
2010 Cella M, Presti R, Vermi W, Lavender K, Turnbull E, Ochsenbauer-Jambor C, Kappes JC, Ferrari G, Kessels L, Williams I, McMichael AJ, Haynes BF, Borrow P, Colonna M, et al. Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection. European Journal of Immunology. 40: 949-54. PMID 20201043 DOI: 10.1002/Eji.200940234  0.391
2009 Loh J, Zhao G, Presti RM, Holtz LR, Finkbeiner SR, Droit L, Villasana Z, Todd C, Pipas JM, Calgua B, Girones R, Wang D, Virgin HW. Detection of novel sequences related to african Swine Fever virus in human serum and sewage. Journal of Virology. 83: 13019-25. PMID 19812170 DOI: 10.1128/Jvi.00638-09  0.612
2008 Tassi I, Cella M, Presti R, Colucci A, Gilfillan S, Littman DR, Colonna M. NK cell-activating receptors require PKC-theta for sustained signaling, transcriptional activation, and IFN-gamma secretion. Blood. 112: 4109-16. PMID 18784374 DOI: 10.1182/Blood-2008-02-139527  0.361
2008 Dunay IR, Damatta RA, Fux B, Presti R, Greco S, Colonna M, Sibley LD. Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity. 29: 306-17. PMID 18691912 DOI: 10.1016/J.Immuni.2008.05.019  0.32
2007 Fehniger TA, Cai SF, Cao X, Bredemeyer AJ, Presti RM, French AR, Ley TJ. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity. 26: 798-811. PMID 17540585 DOI: 10.1016/J.Immuni.2007.04.010  0.318
2007 Wilson TJ, Presti RM, Tassi I, Overton ET, Cella M, Colonna M. FcRL6, a new ITIM-bearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection. Blood. 109: 3786-93. PMID 17213291 DOI: 10.1182/Blood-2006-06-030023  0.396
2006 Fehniger TA, Cai SF, Cao X, Bredemeyer AJ, Presti RM, French AR, Ley TJ. Murine NK Cells Require Activation-Dependent Expression of Granzyme B and Perforin To Become Potent Cytotoxic Effectors. Blood. 108: 920-920. DOI: 10.1182/Blood.V108.11.920.920  0.347
2005 Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M. Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors. Journal of Immunology (Baltimore, Md. : 1950). 175: 749-54. PMID 16002670 DOI: 10.4049/Jimmunol.175.2.749  0.371
2001 Presti RM, Popkin DL, Connick M, Paetzold S, Virgin IV HW. Novel cell type-specific antiviral mechanism of interferon γ action in macrophages Journal of Experimental Medicine. 193: 483-496. PMID 11181700 DOI: 10.1084/Jem.193.4.483  0.648
1999 Virgin IV HW, Presti RM, Li XY, Liu C, Speck SH. Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice Journal of Virology. 73: 2321-2332. PMID 9971815 DOI: 10.1128/Jvi.73.3.2321-2332.1999  0.344
1998 Presti RM, Pollock JL, Dal Canto AJ, O'Guin AK, Virgin IV HW. Interferon γ regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels Journal of Experimental Medicine. 188: 577-588. PMID 9687534 DOI: 10.1084/Jem.188.3.577  0.646
1997 Pollock JL, Presti RM, Paetzold S, Virgin IVth HW. Latent murine cytomegalovirus infection in macrophages Virology. 227: 168-179. PMID 9007070 DOI: 10.1006/Viro.1996.8303  0.396
Show low-probability matches.